Spots Global Cancer Trial Database for A Study of MORAb-003 in Patients With Solid Tumor
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of MORAb-003 in Patients With Solid Tumor
Official Title: A Phase 1 Study of MORAb-003 in Patients With Solid Tumor
Study ID: NCT01049061
Interventions
Study Description
Brief Summary: MORAb-003 is intravenously administered to Japanese patients with folate receptor-alpha expressing solid tumor once a week for 4 weeks as 1 cycle in order to investigate dose-limiting toxicity and estimate maximum tolerated dose.
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Hidaka-shi, Saitama, Japan
, Chuo-ku, Tokyo, Japan
Contact Details
Name: Chifumi Kitamura
Affiliation: JAC PCU Eisai Co., Ltd.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
